Literature DB >> 274171

A fatal myeloproliferative syndrome in a family with thrombocytopenia and platelet dysfunction.

R E Luddy, L A Champion, A D Schwartz.   

Abstract

Three siblings with a lifelong history of a bleeding disorder and thrombocytopenia died from a myeloproliferative disease. In 2, the terminal event resembled juvenile chronic myelogenous leukemia, and in the third, the diagnosis was acute monocytic leukemia. A family study revealed that the mother and 5 other siblings had a variety of hematologic abnormalities. These included chronic thrombocytopenia, abnormal platelet function, elevated concentrations of HgbF or serum vitamin B12, and low leukocyte alkaline phosphatase (LAP) scores either singly or in combination. At the time of study, none had evidence of malignancy. Members of this family have a myeloproliferative disorder that has the potential for terminating in nonlymphocytic leukemia, a combination of events which appears not to have been reported previously.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 274171     DOI: 10.1002/1097-0142(197805)41:5<1959::aid-cncr2820410540>3.0.co;2-8

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

Review 1.  Role of RUNX1 in hematological malignancies.

Authors:  Raman Sood; Yasuhiko Kamikubo; Paul Liu
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

2.  How I diagnose and manage individuals at risk for inherited myeloid malignancies.

Authors: 
Journal:  Blood       Date:  2016-07-28       Impact factor: 22.113

Review 3.  Myeloid neoplasms with germ line RUNX1 mutation.

Authors:  Yoshihiro Hayashi; Yuka Harada; Gang Huang; Hironori Harada
Journal:  Int J Hematol       Date:  2017-05-22       Impact factor: 2.490

Review 4.  The role of the AML1 transcription factor in leukemogenesis.

Authors:  R B Lorsbach; J R Downing
Journal:  Int J Hematol       Date:  2001-10       Impact factor: 2.490

5.  Hereditary hepatosplenomegaly.

Authors:  D S Cheng; H J Williams; M Kitahara
Journal:  West J Med       Date:  1980-01

6.  Neonatal chronic myeloid leukaemia with prolonged survival.

Authors:  D J Moir; P M Emerson; M Holmes-Siedle; M W Moncrieff; H Ellis
Journal:  Arch Dis Child       Date:  1983-01       Impact factor: 3.791

Review 7.  Familial myelodysplastic syndromes: a review of the literature.

Authors:  Elena Liew; Carolyn Owen
Journal:  Haematologica       Date:  2011-05-23       Impact factor: 9.941

8.  Detection of an Abnormal Myeloid Clone by Flow Cytometry in Familial Platelet Disorder With Propensity to Myeloid Malignancy.

Authors:  Chi Young Ok; Vasiliki Leventaki; Sa A Wang; Courtney Dinardo; L Jeffrey Medeiros; Sergej Konoplev
Journal:  Am J Clin Pathol       Date:  2016-01-22       Impact factor: 2.493

9.  Study of inherited thrombocytopenia resulting from mutations in ETV6 or RUNX1 using a human pluripotent stem cell model.

Authors:  Sara Borst; Catriana C Nations; Joshua G Klein; Giulia Pavani; Jean Ann Maguire; Rodney M Camire; Michael W Drazer; Lucy A Godley; Deborah L French; Mortimer Poncz; Paul Gadue
Journal:  Stem Cell Reports       Date:  2021-05-20       Impact factor: 7.765

10.  Two novel RUNX1 mutations in a patient with congenital thrombocytopenia that evolved into a high grade myelodysplastic syndrome.

Authors:  Jessica M Schmit; Daniel J Turner; Robert A Hromas; John R Wingard; Randy A Brown; Ying Li; Marilyn M Li; William B Slayton; Christopher R Cogle
Journal:  Leuk Res Rep       Date:  2015-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.